Answers are grounded in this paper and cite their sources.
In situ synthesis creates dipyrromethanes with anticholinesterase effects, indicating potential for Alzheimer's treatment.
This study reports the in situ hemisynthesis of two novel dipyrromethanes (DPM-1 and DPM-2) from ethyl 1,2-dimethyl-1H-pyrrole-3-carboxylate and natural aldehydes: perillaldehyde from Ammodaucus leucotrichus and cuminaldehyde from cumin seed essential oil. The compounds were synthesized via a double Friedel-Crafts reaction under two catalytic systems: (i) water/ethanol (1:1 v/v) with 0.18 M HCl, and (ii) iodine-catalyzed chloroform. Structural elucidation was achieved using ¹H NMR,¹³C NMR, HSQC, HMBC, and HR-MS. Both derivatives showed significant inhibitory activity against AChE and BChE. DPM-2 was more active against AChE (IC₅₀ = 22.6 ± 0.06 μM) than DPM-1 (IC₅₀ = 51 ± 1.74 μM), and comparable to Galantamine (IC₅₀ = 21.81 ± 1.15 μM). Regarding BChE, DPM-2 (IC₅₀ = 115 ± 1.91 μM) exhibited greater inhibitory potency than DPM-1 (IC₅₀ = 230.41 ± 0.75 μM), and remained close to Galantamine (IC₅₀ = 120.93 ± 1.99 μM). In silico analysis supported their potential as anti-Alzheimer's agents.
No takes yet. Share an insight, caveat, or question.
Maadadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: